↓ Skip to main content

The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes

Overview of attention for article published in Reviews in Endocrine and Metabolic Disorders, January 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
14 X users
patent
4 patents
f1000
1 research highlight platform

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
40 Mendeley
Title
The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes
Published in
Reviews in Endocrine and Metabolic Disorders, January 2020
DOI 10.1007/s11154-019-09536-6
Pubmed ID
Authors

Daniela Regazzo, Mattia Barbot, Carla Scaroni, Nora Albiger, Gianluca Occhi

X Demographics

X Demographics

The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Other 5 13%
Researcher 4 10%
Student > Doctoral Student 4 10%
Student > Postgraduate 4 10%
Student > Ph. D. Student 3 8%
Other 8 20%
Unknown 12 30%
Readers by discipline Count As %
Medicine and Dentistry 15 38%
Biochemistry, Genetics and Molecular Biology 5 13%
Agricultural and Biological Sciences 4 10%
Unspecified 1 3%
Decision Sciences 1 3%
Other 1 3%
Unknown 13 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 June 2023.
All research outputs
#2,332,776
of 24,938,276 outputs
Outputs from Reviews in Endocrine and Metabolic Disorders
#96
of 536 outputs
Outputs of similar age
#54,806
of 470,068 outputs
Outputs of similar age from Reviews in Endocrine and Metabolic Disorders
#4
of 15 outputs
Altmetric has tracked 24,938,276 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 536 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.9. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 470,068 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.